RFI 36C26227Q0026 GANGLIOSIDE GM1.pdf

Sources Sought Notice

*= Required Field Sources Sought Notice

SUBJECT* Ganglioside GM1

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE* 90815

SOLICITATION NUMBER* 36C26227Q0026

RESPONSE DATE/TIME/ZONE 10-21-2026 4:00 PM PST, USA

ARCHIVE 2 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS N

SET-ASIDE

PRODUCT SERVICE CODE* 6515

NAICS CODE* 339112

CONTRACTING OFFICE ADDRESS Department of Veterans Affairs

Network Contracting Office 22

4811 Airport Plaza Drive

Suite 600

Long Beach CA 90815

POINT OF CONTACT*

Contract Specialist (Contractor)

Wilbert Parks

Wilbert.Parks@va.gov

304-263-0811

PLACE OF PERFORMANCE

ADDRESS Phoenix Veterans Affairs Health Care System

650 East Indian School Road

Building 21, Room 116

Phoenix Arizona

POSTAL CODE 85012

COUNTRY USA

ADDITIONAL INFORMATION

AGENCY’S URL https://www.va.gov

URL DESCRIPTION Agency Website

AGENCY CONTACT’S EMAIL ADDRESS Wilbert.Parks@va.gov

EMAIL DESCRIPTION

DESCRIPTION

THIS REQUEST FOR INFORMATION (RFI)/SOURCES SOUGHT NOTICE IS ISSUED

SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A

SOLICITATION.

SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET,

AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI

FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e).

DISCLAIMER

This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.

SOURCES SOUGHT/RFI DESCRIPTION

BRAND NAME/PART #QUANTITY

Avanti Polar Ganglioside GM1 cat# A86065 24 EA

EQUAL TO PRODUCT

GANGLIOSIDE GM1

SALIENT CHARACTERISTICS

1. Ganglioside GM1 must be sourced from ovine brain.

2. Ganglioside GM1 must have a purity greater than 99%.

3. Ganglioside GM1 must be supplied as a 25 mg powder.

4. Ganglioside GM1 must be white in color.

5. Ganglioside GM1 must have a stability of one year or greater.

6. Ganglioside GM1 must have a formula weight of 1568.8 g/mol.

7. Ganglioside GM1 must not be hygroscopic.

8. Ganglioside GM1 must not be light sensitive.

9. Ganglioside GM1 must have a storage temperature of -20°C with an acceptable range of -25°C to

-15°C.

If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions:

(1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of DRAFT/SALIENT CHARACTERISTICS/SOW requirements. For instances where your company cannot meet the DRAFT/SALIENT CHARACTERISTICS/SOW requirement(s), please explain. For instances where your company can meet the

DRAFT/SALIENT CHARACTERISTICS/SOW requirement(s), please show how your company meets/exceeds each requirement.

(2) Please review the list of DRAFT/SALIENT CHARACTERISTICS/SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A.

(3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small

Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc.

(4) Is your company considered small under the NAICS code identified in this RFI?

(5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of DRAFT/SALIENT

CHARACTERISTICS/SOW?

(6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available).

(7) If you’re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified.

(8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6?

(9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items?

(10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice?

(11) What is your lead time to deliver a single unit with all components? Is there scale in lead time with greater quantities? Please elaborate.

(12) What is estimated life span of your solution? What support/services does that entail?

(13) Does your proposed equipment have FDA clearance? Please specify what FDA clearance(s) have been obtained.

(14) Does your organization offer a leasing solution? Please elaborate.

(15) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA

SEWP or any other Federal Government contract? If so, please provide the contract number(s).

(16) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract.

(17) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award.

(18) Please provide your SAM.gov Unique Entity ID/Cage Code number.

Buy America Compliance

Respondents shall provide sufficient detail to determine compliance with the Buy American

Act, including country of origin, domestic content, and availability of domestic alternatives.

Responses should be complete and supported with verifiable information.

1. Please identify the country of origin for the end product(s) being offered. Include the location of final assembly/manufacture.

2. Please provide the percentage of domestic content (by cost) for each product(s).

Describe the origin of the major components.

3. Does your product qualify as a “domestic end product” in accordance with the Buy

American Act?

4. If the proposed product is not compliant, are you able to provide a BAA-compliant domestic alternative?

5. Please identify the manufacturer name and location for the product(s). Confirm whether the manufacturer is U.S.-based.

6. Identify the country of origin of each product and indicate whether the product qualifies as a U.S.-made or designated-country end product in accordance with the

Trade Agreements Act

Responses to this notice shall be submitted via email to wilbert.parks@va.gov. Telephone responses will not be accepted. Responses must be received no later than Wednesday, October 21,2026 by 4:00

PM PST.

All responses to this Sources Sought/RFI will be used for planning purposes only. Responses to this Sources Sought Notice / RFI are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued as a result of the information provided from this RFI, all interested parties must respond to the specific posting separately IAW the specifications of that announcement.